Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 880 results for "sanofi"

Shantha Bio gets first prize in quality systems

Shantha Biotechnics, a Sanofi company, has received first prize in medium-size category of manufacturers. Quality Council of India chairman Adil Zainulbhai gave away the awards at the 5th FICCI quality systems excellence awards ceremony. The ... The Hindu, 1 day ago

877 images for sanofi

WKRB News, 1 day ago
Yahoo! UK and Ireland, 2 days ago
Yahoo! Finance UK and Ireland, 2 days ago, 2 days ago
Yahoo! UK and Ireland, 2 days ago
World Pharma News, 5 days ago
Reuters, 2 days ago
Brief, 2 days ago, 2 days ago
Pharma Letter, 3 days ago
Money Control

FIPB clears 6 FDI proposals worth Rs 1,187 crore

NEW DELHI: Inter-ministerial body FIPB today approved six investment proposals, including that of Sanofi Synthelabo India, Star Den Media Services and Idea Cellular Infrastructure Services, envisaging foreign investments of Rs 1,186.5 crore. Of the ...
 Economic Times3 days ago Sanofi among six FDI proposals worth ₹1,186.5 crore cleared  Business Line3 days ago FIPB approves 6 FDI proposals worth Rs 1,200 crore  India Infoline3 weeks ago Foreign Investment Promotion Board clears FDI schemes  India Infoline2 days ago

Bay State Biotech Report: Drugmakers Focus on Pandemics

Spurred by the Ebola and Zika epidemics, GlaxoSmithKline, Johnson & Johnson and Sanofi are among drugmakers backing an effort to develop new vaccines that could be deployed swiftly to contain outbreaks before they spark global emergencies. And ...
 Bloomberg2 days ago Ebola, Zika Push Drugmakers to Join Effort to Avert Pandemics  Yahoo! Finance3 days ago Drugmakers back vaccine development to contain outbreak emergencies  Business Live South Africa2 days ago News Ebola, Zika Push Drugmakers to Join Effort to Avert Pandemics  Jakarta Post3 days ago

Suliqua approved in EU for the treatm...

The European Commission has granted marketing authorisation in Europe for SuliquaTM,Sanofi's once-daily titratable fixed-ratio combination of basal insulin glargine 100 Units/mL and GLP-1 receptor agonist lixisenatide for the treatment of adults ...
 Pharma Field3 days ago Sanofi : EU Approves Suliqua To Treat Adults With Type 2 Diabetes  RTTNews.com4 days ago EU approval of Suliqua triggers USD 10 million milestone payment to Zealand  FirstWord Pharma4 days ago SANOFI : EU approval of Suliqua(TM) triggers USD 10 million milestone payment to Zealand  4 Traders4 days ago
Money Control

Sanofi's M&A misses frustrate some investors in drugmaker

* Investors growing impatient after it fails to land acquisitions * CEO says unwilling to pay too much, cites lack of opportunities * Sanofi misses underscore race for assets at drugmakers * Investors say cost cutting not enough, want sales ...
 Yahoo! Finance2 days ago Restless Sanofi investors want it to get its M&A act together  FiercePharma1 day ago Investors Frustrated as Sanofi CEO Fails to Make a M&A Deal  BioSpace1 day ago INSIGHT-Sanofi's M&A misses frustrate some investors in drugmaker (SAN, JNJ, PFE)  Business Insider2 days ago

Sanofi diabetes combo approved in EU

Sanofi's type 2 diabetes combination drug Suliqua has been approved in Europe setting the scene for a showdown with Novo Nordisk's rival, Xultophy. The EU approval means Sanofi and Novo Nordisk both have competing combination therapies approved ...
 pharmaphorum2 days ago BRIEF-Sanofi receives EU greenlight for diabetes treatment Suliqua  Reuters UK4 days ago eu approves suliqua for type 2 diabetes treatment  HCPLive4 days ago

Extended FDA Review for Lilly/Incyte's Olumiant (baricitinib) in Rheumatoid Arthritis Delays Market Entry for First Major Competitor to Pfizer's Xeljanz

And Sanofi-Regeneron's IL-6 inhibitor, sarilumab, also getting back on track after receiving a Complete Response Letter from the FDA in October 2016. The competition to be the preferred first-line, non-TNF agent in the treatment RA is expected to be ...
 Benzinga.com3 days ago

Vet med industry now dominated by four firms; further mergers unlikely

With the recent sign-off from the U.S. Federal Trade Commission, privately held Boehringer Ingelheim is set absorb Sanofi's ( SNY -0.1%) animal health unit Merial, making it the number two player in the veterinary medicine field behind Zoetis ( ZTS ...
 Seeking Alpha3 days ago

Sanofi Diabetes Drug Suliqua Wins EU Marketing Approval

Sanofi SNY announced that the European Commission has granted marketing authorization to its once-daily injection, Suliqua a combination of diabetes drugs Lantus and lixisenatide (EU trade name: Lyxumia) for the treatment of diabetes. The drug was ...
 Yahoo! Finance3 days ago

Sanofi buys 87,298 shares of Regeneron's common stock on Jan 11

Eikon Information, analytics and exclusive news on financial markets - delivered in an intuitive desktop and mobile interface Elektron Everything you need to empower your workflow and enhance your enterprise data management ...
 Reuters UK6 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less